Literature DB >> 18425375

Expression of Sonic hedgehog signaling pathway correlates with the tumorigenesis of intraductal papillary mucinous neoplasm of the pancreas.

Kennichi Satoh1, Atsushi Kanno, Shin Hamada, Morihisa Hirota, Jun Umino, Atsushi Masamune, Shinichi Egawa, Fuyuhiko Motoi, Michiaki Unno, Tooru Shimosegawa.   

Abstract

Sonic hedgehog (SHH) is frequently expressed in pre-cancerous lesions and carcinoma of the pancreas. A recent study revealed that its expression was higher in the intraductal papillary mucinous neoplasm (IPMN) of the pancreas than in the pancreatic carcinoma. However, the correlation between its signaling pathway and tumorigenesis of IPMN has not yet been well documented. We investigated the expression of mRNA and protein of SHH as well as its downstream transcription factor Gli1 in 19 microdissected lesions from 15 cases and in 75 lesions from 33 cases of the IPMN by one-step quantitative real-time reverse transcription-polymerase chain reaction and immunohistochemistry, respectively. SHH and Gli1 mRNAs were detected in all the examined lesions and 8 out of 19 lesions in IPMNs, respectively. SHH and Gli1 mRNAs were likely to be up-regulated from the adenoma and from borderline to carcinoma cells, respectively. Immunohistochemical analysis also reported that SHH and Gli1 expression was correlated with the grade of cell atypia. These findings suggested that HH signaling was activated in IPMNs and contributed to tumorigenesis in these types of neoplasms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18425375

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  10 in total

Review 1.  Molecular pathology of intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Marina Paini; Stefano Crippa; Stefano Partelli; Filippo Scopelliti; Domenico Tamburrino; Andrea Baldoni; Massimo Falconi
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 2.  Intraductal papillary mucinous tumors of the pancreas: biology, diagnosis, and treatment.

Authors:  Robert Grützmann; Marco Niedergethmann; Christian Pilarsky; Günter Klöppel; Hans D Saeger
Journal:  Oncologist       Date:  2010-12-08

3.  Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes.

Authors:  Mari Mino-Kenudson; Carlos Fernández-del Castillo; Yoshifumi Baba; Nakul P Valsangkar; Andrew S Liss; Maylee Hsu; Camilo Correa-Gallego; Thun Ingkakul; Rocio Perez Johnston; Brian G Turner; Vasiliki Androutsopoulos; Vikram Deshpande; Deborah McGrath; Dushyant V Sahani; William R Brugge; Shuji Ogino; Martha B Pitman; Andrew L Warshaw; Sarah P Thayer
Journal:  Gut       Date:  2011-04-20       Impact factor: 23.059

4.  Expression of Gli1 and PARP1 in medulloblastoma: an immunohistochemical study of 65 cases.

Authors:  Joze Pizem; Mara Popovic; Andrej Cör
Journal:  J Neurooncol       Date:  2010-10-16       Impact factor: 4.130

5.  Genetic markers of malignant transformation in intraductal papillary mucinous neoplasm of the pancreas: a meta-analysis.

Authors:  Sahar Nissim; Gregory E Idos; Bechien Wu
Journal:  Pancreas       Date:  2012-11       Impact factor: 3.327

Review 6.  Can we better predict the biologic behavior of incidental IPMN? A comprehensive analysis of molecular diagnostics and biomarkers in intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Kiara A Tulla; Ajay V Maker
Journal:  Langenbecks Arch Surg       Date:  2017-12-07       Impact factor: 3.445

7.  Tracking down the hedgehog's lair in the pancreas.

Authors:  Anirban Maitra
Journal:  Gastroenterology       Date:  2010-01-25       Impact factor: 22.682

8.  Expression of MSX2 predicts malignancy of branch duct intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Kennichi Satoh; Shin Hamada; Atsushi Kanno; Morihisa Hirota; Jun Umino; Hiromichi Ito; Atsushi Masamune; Shinichi Egawa; Michiaki Unno; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2010-01-28       Impact factor: 7.527

9.  MSX2 in pancreatic tumor development and its clinical application for the diagnosis of pancreatic ductal adenocarcinoma.

Authors:  Kennichi Satoh; Shin Hamada; Tooru Shimosegawa
Journal:  Front Physiol       Date:  2012-11-14       Impact factor: 4.566

10.  Derivation of high purity neuronal progenitors from human embryonic stem cells.

Authors:  Gabriel Nistor; Monica M Siegenthaler; Stephane N Poirier; Sharyn Rossi; Aleksandra J Poole; Maura E Charlton; John D McNeish; Chris N Airriess; Hans S Keirstead
Journal:  PLoS One       Date:  2011-06-06       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.